ACCESS Newswire

How Much Do Vegan Diets Improve the Health of Dogs?

5.9.2024 14:00:00 CEST | ACCESS Newswire | Press release

Share

WINCHESTER, UK / ACCESSWIRE / September 5, 2024 / Pet food consumes at least 9% of all livestock globally, rising to 20% in nations such as the US with high pet ownership. The environmental benefits of vegan pet diets were recently found to be game-changingly large. Most of these relate to dog food. But, can dogs be healthy without consuming meat?

Dogs are biologically omnivores, and many companies now produce vegan dog food using plant, mineral and synthetic ingredients to supply all necessary nutrients. By 2024, 10 scientific studies had demonstrated good health outcomes in dogs fed vegan or vegetarian diets, and the British Veterinary Association had endorsed nutritionally-sound vegan dog diets. Yet no studies had calculated the size of the health benefits that might occur for average dogs, after controlling for age, sex, neutering status, breed size and exercise level - all factors that can affect dog health.

In 2024 veterinary Professor Andrew Knight and two colleagues published the first study to control for all of these factors. After analysing health outcomes for 2,536 dogs, including 336 fed a vegan diet for at least one year, they found decreases in the occurrences of seven general indicators of illness. Dogs fed vegan diets were less likely to need medication, medical diets or unusually high numbers of veterinary visits, were more likely to be assessed as healthy by dog owners and their veterinarians, had lower rates of illness, and fewer cases of health disorders when they were unwell. Reductions ranged from 14% - 51% for average dogs, compared to dogs fed conventional meat-based diets. All of these differences were statistically significant, meaning they almost certainly reflected true differences rather than random variation.

Additionally, the odds of suffering from six specific health disorders fell by 50%-61% compared to dogs fed conventional meat. These included some of the most common health disorders in dogs: problems with body weight, ears, and the musculoskeletal and gastrointestinal system ­- which can cause conditions such as lameness and diarrhoea.

Among the 22 most common health disorders found in a 2022 study of the same dogs, 11 were most common in dogs fed conventional meat, eight in dogs fed raw meat, and three most common in dogs few vegan diets. 49% of dogs fed conventional meat were unwell, compared to 43% fed raw meat, and 36% fed vegan diets.

Stated Prof. Knight, "Dogs fed vegan diets clearly had the best health outcomes in this very large-scale study, and these results are consistent with prior studies in this field. Nutritionally-sound vegan diets offer extremely large environmental benefits, so this is very good news for dog owners who want to protect the environment whilst also maximising their dogs' health. However, care should always be taken to ensure diets are nutritionally-sound, by checking package labelling and purchasing from reputable pet food companies."

Contact Information

Andrew Knight
Veterinary Professor of Animal Welfare
andrew.knight@murdoch.edu.au

SOURCE: Prof. Andrew Knight

View the original press release on newswire.com.

Representing Animals Foundation

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

GTDC Highlights Distributors' Vital Role in Scaling AI Adoption and Digital Transformation15.4.2026 15:00:00 CEST | Press release

Industry leaders stress that digital platforms, support, and collaboration are essential to boost sales, engage channels, and respond to shifts in global trade, workforce shortages, and the rise of robotics and AI. Technology distribution is evolving as these "AI-first" partners emerge, developing and deploying original AI solutions that define a new era of applied AI. IT distributors help speed up cloud, AI, and emerging tech adoption by investing in advanced systems and services for vendors and solution providers. NOORDWIJK, NL / ACCESS Newswire / April 15, 2026 / IT distributors have become a driving force behind the sales and adoption of AI, advanced cloud and cybersecurity solutions and other next‑generation technologies based on research and discussions at this week's GTDC Summit EMEA conference. The quickly evolving digital landscape was a central theme of the annual channel executive event, hosted by the Global Technology Distribution Council (GTDC), the world's largest consort

GTDC Highlights Distributors' Vital Role in Scaling AI Adoption and Digital Transformation15.4.2026 15:00:00 CEST | Press release

Industry leaders stress that digital platforms, support, and collaboration are essential to boost sales, engage channels, and respond to shifts in global trade, workforce shortages, and the rise of robotics and AI. Technology distribution is evolving as these "AI-first" partners emerge, developing and deploying original AI solutions that define a new era of applied AI. IT distributors help speed up cloud, AI, and emerging tech adoption by investing in advanced systems and services for vendors and solution providers. NOORDWIJK, NL / ACCESS Newswire / April 15, 2026 / IT distributors have become a driving force behind the sales and adoption of AI, advanced cloud and cybersecurity solutions and other next‑generation technologies based on research and discussions at this week's GTDC Summit EMEA conference. The quickly evolving digital landscape was a central theme of the annual channel executive event, hosted by the Global Technology Distribution Council (GTDC), the world's largest consort

Innodata to Report First Quarter 2026 Results15.4.2026 14:00:00 CEST | Press release

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report First Quarter 2026 results after the market closes on Thursday, May 7, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 715 9871 North America, Toll Free (+44) 800 358 0970 United Kingdom (+1) 646 307 1963 International Participant Access Code 3150581 For Replay: (+1) 800 770 2030 North America-Toll Free (+1) 609 800 9909 International Playback ID 3150581 Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be available

Innodata to Report First Quarter 2026 Results15.4.2026 14:00:00 CEST | Press release

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report First Quarter 2026 results after the market closes on Thursday, May 7, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 715 9871 North America, Toll Free (+44) 800 358 0970 United Kingdom (+1) 646 307 1963 International Participant Access Code 3150581 For Replay: (+1) 800 770 2030 North America-Toll Free (+1) 609 800 9909 International Playback ID 3150581 Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be available

Envision Pharma Group Strengthens Executive Leadership Team to Accelerate Growth, Innovation and Global Client Delivery15.4.2026 14:00:00 CEST | Press release

Two Senior Appointments Reinforce Commitment to Technology Integration and Scalable Pharmaceutical Services FAIRFIELD, CT / ACCESS Newswire / April 15, 2026 / Envision Pharma Group (Envision), a global, technology-enabled solutions partner to the life sciences industry, has appointed two senior executives to further strengthen its leadership team and focus on integrating innovative AI technologies across its portfolio to deliver more data-driven outcomes for clients. Jay Ferro has been appointed President, Technology and Chief Product Officer. He joins Envision from Clario, a global clinical trial endpoint and technology company, where he led platform modernization and operational transformation initiatives that helped position the company for its acquisition in October 2025. Ferro will oversee a combined technology and product organization responsible for shaping enterprise technology strategy, translating business needs into scalable product solutions, and ensuring investments align

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye